When standard ophthalmology reaches its limits—whether due to chronic dry eye, macular edema, or optic nerve damage that has stabilized—patients often hear that nothing more can be done. Yet in medical practice, acupuncture is increasingly documented as an adjunctive therapy that influences local blood flow and neuro-inflammatory markers, not as a cure but as a management tool. For conditions like retinitis pigmentosa or non-arteritic anterior ischemic optic neuropathy, where conventional treatments offer little, some clinicians refer patients to licensed acupuncturists who use periocular and distal points to modulate autonomic tone. One practical point is to request a baseline visual field test and tear film analysis before starting sessions, so any changes can be measured objectively. Another is to expect a minimum of 10–12 weekly treatments before judging efficacy, as ocular microcirculation responds slowly. A third is to continue all prescribed eye drops or oral medications during acupuncture—this therapy is supportive, not substitutive. If you are exploring this path, reviewing the protocols used at Boel Akupunktur Haslev may clarify what a structured medical-adjacent approach looks like, including point selection for glaucoma or diabetic retinopathy. The evidence base remains preliminary, but for patients with untreatable vision loss, the risk profile is low, and the potential for symptomatic relief—such as reduced floaters or improved contrast sensitivity—should not be dismissed outright.
No comments:
Post a Comment